Successful treatment of CRPS 1 with anti-TNF.
Huygen
Frank J P M
FJ
Niehof
Sjoerd
S
Zijlstra
Freek J
FJ
van Hagen
P Martin
PM
van Daele
Paul L A
PL
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D001768:Blister / Q000097:blood*; D006801:Humans; D000069285:Infliximab; D015850:Interleukin-6 / Q000097:blood*; D008875:Middle Aged; D010147:Pain Measurement / Q000379:methods*; D012019:Reflex Sympathetic Dystrophy / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis* / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab